AbbVie and Voyager Therapeutics team up for Alzheimer’s gene therapy – Chemical & Engineering News
Chemical & Engineering News |
AbbVie and Voyager Therapeutics team up for Alzheimer's gene therapy
Chemical & Engineering News Antibodies that target tau or amyloid-β are in development at many companies, but they aren't always able to reach the brain in large numbers, even though injections of the drugs are typically given repeatedly. In contrast, a one-time injection of … AbbVie, Voyager Launch Up-to-$1.1B+ Gene–Therapy Collaboration to Treat Alzheimer's, Neurodegenerative Diseases Cambridge's Voyager, AbbVie to pursue Alzheimer's gene therapy under $69M deal Xconomy: With $69M Deal, AbbVie Turns to Voyager for an … |
